Top

Published in:

01-10-2003 | Original

Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction

Authors: Rochus Witthaut, Christian Busch, Peter Fraunberger, Autar Walli, Dietrich Seidel, Günter Pilz, Ralph Stuttmann, Norbert Speichermann, Ljifane Verner, Karl Werdan

Published in: Intensive Care Medicine | Issue 10/2003

Abstract

Objective

Interest has recently focused on the use of neurohormonal markers such as atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) as indices of left ventricular systolic dysfunction and prognosis in heart failure. Also, peptides belonging to the interleukin-6 (IL-6) family have been shown to induce ANP and BNP secretion. We hypothesized that BNP and ANP spillover in the peripheral circulation reflects left ventricular dysfunction and IL-6 production in septic shock.

Design and setting

Retrospective, clinical study in the medical intensive care unit of a university hospital.

Patients and participants

17 patients with septic shock and 19 control subjects.

Interventions

Collection of clinical and demographic data in relation to ANP, BNP, IL-6, and soluble TNF receptors (sTNF-R-p55, sTNF-R-p75) in plasma over a period of 4 days.

Measurements and results

In septic shock we found a significant increase in ANP (82.7±9.9 vs. 14.9±1.2 pg/ml) and BNP (12.4±3.6 vs. 5.5±0.7 pg/ml). Plasma ANP peaked together with IL-6. Peaks of ANP and IL-6 were significantly correlated (r=0.73; p<0.01). BNP was inversely correlated to cardiac index (r=–0.56; p<0.05).

Conclusions

ANP and BNP increase significantly in patients with septic shock. BNP reflects left ventricular dysfunction. ANP is related to IL-6 production rather than to cardiovascular dysfunction.

Nakao K, Ogawa Y, Suga S, Imura H (1992) Molecular biology and biochemistry of the natriuretic system. I. Natriuretic peptides. J Hypertens 10:907–912PubMed

Bold AJ de (1985) Atrial natriuretic factor: a hormone produced by the heart. Science 230:767–770PubMed

Sudoh T, Kangawa K, Minamino N, Matsuo H (1988) A new natriuretic peptide in porcine brain. Nature 332:78–81CrossRefPubMed

Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195–203PubMed

Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H (1990) Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 313:757–758

Gottlieb S, Kukin ML, Ahern D, Packer M (1989) Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13:153–159PubMed

Arakawa N, Nakamura M, Aoki H, Hiramori K (1996) Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27:1656–1661CrossRefPubMed

Hall C, Rouleau JL, Moye L, de Champlain J, Bichet D, Klein M, Sussex B, Packer M, Rouleau J, Arnold MO, Lamas GA, Sestier F, Gottlieb S, Wun CC, Pfeffer MA (1994) N terminal proatrial natriuretic factor. An independent predictor of long term prognosis after myocardial infarction. Circulation 89:1934–1942PubMed

Thaik CM, Calderone A, Takahashi N, Colucci WS (1995) Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 96:1093–1099PubMed

10.

He Q, LaPointe MC (1999) Interleukin-1β regulation of the human brain natriuretic peptide promotor involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 33:283–289PubMed

11.

Kuwahara K, Saito Y, Harada M, Ishikawa M, Ogawa E, Miyamoto Y, Hamanaka I, Kamitani S, Kajiyama N, Takahashi N, Nakagawa O, Masuda I, Nakao K (1999) Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 100:1116–1124PubMed

12.

MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S (1997) Circulating interleukin-6 in severe heart failure. Am J Cardiol 79:1128–1131CrossRefPubMed

13.

Talwar S, Downie PF, Squire IB (1999) An immunolumino-metric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure. Biochem Biophys Res Commun 261:567–571CrossRefPubMed

14.

Tsutamoto T, Hisanga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabushi N, Sawaki M, Kinoshita M (1998) Interleukin-6 spillover in the peripheral circulation increase with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391–398PubMed

15.

Talwar S, Squire IB, Downie PF, Davies JE, Ng LL (2000) Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84:421–424CrossRefPubMed

16.

Torre-Amione G, Kapadia S, Benedct C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular dysfunction. J Am Coll Cardiol 27:1201–1206PubMed

17.

Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92:2303–2312PubMed

18.

Werdan K (1998) The activated immune system in congestive heart failure-from dropsy to the cytokine paradigm. J Intern Med 243:87–92CrossRefPubMed

19.

Price S, Anning PB, Mitchell JA, Evans TW (1999) Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J 20:715–724CrossRefPubMed

20.

Müller-Werdan U, Werdan K (1999) Septic cardiomyopathy. Curr Opin Crit Care 5:415–421

21.

Parker MM, Shelhamer JH, Natanson C, Alling DW, Parillo JE (1989) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15:923–929

22.

Pilz G, Fateh-Moghadam S, Viell B, Bujdoso O, Döring G, Marget W, Werdan K (1993) Supplemental immunoglobulin therapy in sepsis and septic shock-comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo: protocol of a multicenter, randomized, prospective, double-blind trial. Theor Surg 8:61–83

23.

Werdan K, Pilz G, and the SBITS Study Group (1998). Polyvalent immune globulins. Shock [Suppl] 7:1918

24.

Bone R (1996) Sir Isaac Newton, sepsis, SIRS and CARS. Crit Care Med 24:1125–1128

25.

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874PubMed

26.

Elebute EA, Stoner HB (1983) The grading of sepsis. Br J Surg 70:29–31

27.

Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMed

28.

Gerbes AL, Witthaut R, Gülberg V, Thibault G, Bilzer M, Jüngst D (1992) Role of the liver in splanchnic extraction of atrial natriuretic factor in the rat. Hepatology 16:790–793PubMed

29.

Fraunberger P, Pfeiffer M, Cremer P, Holler E, Nagel D, Dehart I, Thein M, Walli AK, Seidel D (1992) Validation of an automated enzyme immunoassay for interleukin-6 for routine clinical use. Clin Chem Lab Med 36:797–801

30.

Baim DS, Grossman W (1996) Cardiac catheterization, angiography, and intervention, 5th edn. Williams & Wilkins, Baltimore

31.

Muders F, Kromer EP, Griese DP, Pfeifer M, Hense HW, Riegger GAJ, Elsner D (1997) Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 134:442–449PubMed

32.

Bakker J, Vincent JL (1993) Effects of norepinephrine and dobutamine on oxygen transport and consumption in a dog model of endotoxic shock. Crit Care Med 21:1248–1249PubMed

33.

Pilz G, R Appel, P McGinn (1993) Calculation of the left ventricular stroke work index. Crit Care Med 21:1248–1249PubMed

34.

Raine AEG, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR (1986) Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 315:533–537PubMed

35.

Hama N, Ito H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I (1995) Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92:1558–1564PubMed

36.

Ogawa T, Linz W, Stevenson M, Bruneau BG, de Bold MLK, Chen JH, Eid H, Schölkens BA, de Bold AJ (1996) Evidence for load dependent and load independent determinants of cardiac natriuretic peptide production. Circulation 93:2059–2067PubMed

37.

Edwards BS, Zimmermann RS, Schwab TR, Heublin DM, Burnett JC (1988) Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 62:191–195PubMed

38.

Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE (1988) Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 93:903–910PubMed

39.

Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M, Takahashi T, Kato T, and Ogawa S (1999) Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 84:1127–1136PubMed

40.

Tsuruda T, Jougaschi M, Boerrigter G, Huntley BK, Chen HH, Dàssoro AB, Lu SC, Sarson AM, Cataliotti A, Burnett JC Jr (2002) Cardiotrophin-1 stimulation of cardiac fibroblast growth. Roles for glycoprotein 130/ leukemia inhibitory factor receptor and the endothelin type A receptor. Circ Res 90:128–134CrossRefPubMed

Title: Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction
Authors: Rochus Witthaut
Christian Busch
Peter Fraunberger
Autar Walli
Dietrich Seidel
Günter Pilz
Ralph Stuttmann
Norbert Speichermann
Ljifane Verner
Karl Werdan
Publication date: 01-10-2003
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 10/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-1910-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction

Abstract

Objective

Design and setting

Patients and participants

Interventions

Measurements and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design and setting

Patients and participants

Interventions

Measurements and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2003

Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus

Difficult weaning from mechanical ventilation following Wernicke's syndrome developing after gastroplasty

Fluid leakage past tracheal tube cuffs: evaluation of the new Microcuff endotracheal tube

Inhaled nitric oxide for ARDS: searching for a more focused use

What's in a beat?

Inhaled nitric oxide reduces lung edema during fluid resuscitation in ovine acute lung injury